The world’s most pricey drugs, from a $1.2M gene therapy to a $450K lymphoma med – FiercePharma
FiercePharma |
The world’s most pricey drugs, from a $1.2M gene therapy to a $450K lymphoma med
FiercePharma It’s a gene therapy, the first to win a regulatory nod, and on the leading edge of a potential wave of therapies of that ilk, many costing upwards of $1 million or more. Payers and other experts, worried about their advent, have been tossing around … |
OncLive |
Dr. Costa on Biomarkers Beyond PD-L1 for Immunotherapy in NSCLC
OncLive The presence of PD-L1 expression, even at the highest level, doesn’t necessarily predict a 100% response rate to immunotherapy, he says. Researchers are aware that there needs to be more refinements and better patient selection to determine who would … |
搜狐 |
Science Advances：重磅！研究人员使用CRISPR-Cpf1治疗杜氏肌营养不良
搜狐 通过敲除突变区域或精确修复突变基因，CRISPR-Cpf1介导的基因编辑不仅纠正了杜氏肌萎缩症突变，而且还改善了肌肉收缩能力和强度，”分子生物学教授、Hamon再生科学和医学研究中心副主任、Rhonda Bassel的合著者Duby博 … |
Pharmaceutical Processing |
CAR–T Cell Therapy Receives FDA Breakthrough Designation
Pharmaceutical Processing Novartis announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to CTL019, an investigational chimeric antigen receptor T cell (CAR-T) therapy, for the treatment of adult patients with relapsed and … 3 Things In Biotech You Should Learn Today: April 19, 2017Seeking Alpha Novartis’ (NVS) CTL109 BLA Gets Breakthrough Therapy StatusZacks.com Novartis’ lymphoma treatment receives FDA breakthrough therapy designationEuropean Pharmaceutical Review |
News-Medical.net |
IRCM researchers discover how immunotherapy works in some cancer patients
News-Medical.net What if our immune system could cure cancer? This logic seems almost too simple to be true, but it forms the basis of an emerging cancer treatment—immunotherapy. André Veillette, a researcher at the Institut de recherches cliniques de Montréal (IRCM) … |
Laboratory Equipment |
Red-eyed Mutant Wasps Created Using CRISPR
Laboratory Equipment The wasps were created to prove that CRISPR gene-slicing technology can be used successfully on the tiny parasitic jewel wasps, giving scientists a new way to study some of the wasp’s interesting biology, such as how males can convert all their progeny … Scientists Are Making Horrible Red-Eye Mutant Wasps Because Why the Hell NotGizmodo Scientists engineer red-eyed mutant waspsUPI.com Red-eyed mutant wasps created in lab for first timeThe Independent |
BioPharma-Reporter.com |
Synpromics announces £5.2M British investment in gene therapy tech
BioPharma-Reporter.com The promoters allow for precise control of gene function, impacting gene therapy, cell therapy and gene editing. Synpromics CEO David Venables described the distinct nature of the PromPT platform late last year as a “unique capability for the … Synpromics Raises £5.2M of New InvestmentYahoo Finance Biotech firm Synpromics secures £5.2m cash injectionThe Scotsman |